Certain features of the drugs selected for first-year negotiation could limit CMS’s pricing flexibility. To enhance program predictability and provide clear signals to the pharmaceutical industry ...
The drug pricing paradigms of Canada, France, and Germany offer lessons for the United States on how to arrive at a “fair price” for drugs in a predictable and transparent manner. Yet translating a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results